{"schema_version":"secwatch.filing_event.v1","accession":"0001472375-26-000217","form_type":"8-K","ticker":"RGPX","cik":"0001357878","company_name":"REGENEREX PHARMA, INC.","filed_at":"2026-09-04T20:48:09+00:00","discovered_at":"2026-09-04T20:49:04.459694+00:00","generated_at":"2026-09-04T20:49:07.560038+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Regenerex Pharma auditor dbbmckennon resigns; going concern doubt noted","bullets":["dbbmckennon resigned as independent auditor effective Aug 31, 2026, after serving since 2017.","Auditor reports for FY2025 and transition period included going concern explanatory paragraph.","Transition period report also noted revision for related party transaction disclosures.","No disagreements or reportable events in last two fiscal years; company seeking successor auditor.","Company is behind on outstanding periodic reports and will work with successor to catch up."],"urls":{"canonical":"https://secwatch.observer/filing/0001472375-26-000217","json":"https://secwatch.observer/filing/0001472375-26-000217.json","markdown":"https://secwatch.observer/filing/0001472375-26-000217.md","text":"https://secwatch.observer/filing/0001472375-26-000217.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357878/000147237526000217/0001472375-26-000217-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357878/000147237526000217/ixform8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-04T20:49:07.560038+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}